Epoetin omega

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpoetin omega
Drug Alias NameEpoetin ωEpomax/Epomega/Hemax/RepotinHP-EPO-CRF
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsBipolar DisorderAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesElanex Pharma Group
China Registration ClassN/A

Develop Information

Active CompaniesElanex Pharma Group
Inactive CompaniesUniversity Of Cincinnati
Active IndicationsAnemia
Inactive IndicationsBipolar Disorder

Other Information

ATC CodeB03XA01
Related LinksN/A